Nikolaj Christian Torp

Nikolaj Christian Torp is a Research Fellow and Medical Doctor affiliated with the Department of Clinical Research at the University of Southern Denmark (SDU), part of the FLASH - Centre for Liver Research in Odense. He holds an MD (2021) and a bachelor's degree in International Business from Copenhagen Business School (2015). His research focuses on pharmacological treatments for alcoholic liver disease and cirrhosis, including involvement in clinical trials like the Stop Scar Tissue Study (double-blind, placebo-controlled) and the Alb-Trial (multicenter albumin therapy study).

Key responsibilities include participant recruitment, inclusion, and clinical consultations. Since 2018, he has been affiliated with the Center for Liver Research and initiated his PhD in 2022, focusing on human albumin treatment in decompensated cirrhosis patients. His work is part of the EU consortium MicrobPredict. Nikolaj is active on Twitter and LinkedIn.

His research spans liver fibrosis, microbiome interactions, and clinical trial design. Recent studies emphasize prognostic models for fibrosis, alcohol intake discrepancies, and microbiome confounders in liver disease. He collaborates internationally, contributing to projects like the Galaxy initiative.